dangers of glp 1 The GLP-1 Trap: Your Jumpstart Might Be a Forever Commitment GLP-1 medication side effects for
Description
The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes
Add-on value of tirzepatide versus semaglutide
The CVOT of oral semaglutide in people with type 2 diabetes and established CVD, chronic kidney disease (CKD) or both demonstrated a significant reduction in MACE compared with placebo (McGuire et al, 2025)
Mazdutide is supported by robust clinical data published in multiple high-impact journals, including Nature , the Lancet sub-journals, and the New England Journal of Medicine
This was the shortest retatrutide obesity trial, and it STILL has essentially matched bariatric surgery outcomes in terms of weight loss
How might synthetic biology change the future of pharmacology
